CT BUZZ Reporter Jillian Andrews recently spoke with Dr. Zubin Bham, MD a Sleep Medicine specialist from Bridgeport Hospital, about Maskless Sleep Apnea Treatments.For ...

In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...

Many of you are not getting enough sleep. That’s according to a recent study conducted by a University of Alabama professor.

Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the ...

A study reveals sleep apnea can cause brain damage, increasing risks of aging and dementia, particularly in Hispanic seniors.

New research provides guidance on the effects of caffeine, diet and naps on sleep. Plus there are expanded treatments for ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to find out more information.

It’s important to get adequate sleep, but you also want to ensure you’re getting restorative sleep. Investing in a sleep tracker is a great way to figure out whether you’re getting quality ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

Short sleepers cruise by on four to six hours a night and don’t seem to suffer ill effects Marla Broadfoot, Knowable Magazine Some people are genetically built to require less sleep than the ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...